Document is current

Any future updates will be listed below

Correction to: Efficacy and Safety of ABP 798: Results from the JASMINE Trial in Patients with Follicular Lymphoma in Comparison with Rituximab Reference Product

Crossref DOI link: https://doi.org/10.1007/s11523-020-00772-4

Published Online: 2020-11-12

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark